Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
142M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
+24.2M
-
Total reported value, excl. options
-
$488M
-
Value change
-
+$488M
-
Number of buys
-
48
-
Price
-
$20.19
Significant Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) as of Q3 2020
48 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2020.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 142M outstanding shares and own 17.09% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4.95M shares), CITADEL ADVISORS LLC (2.97M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), WELLINGTON MANAGEMENT GROUP LLP (2.54M shares), FRANKLIN RESOURCES INC (1.75M shares), Logos Global Management LP (1.6M shares), JANUS HENDERSON GROUP PLC (986K shares), HILLHOUSE CAPITAL ADVISORS, LTD. (600K shares), PRICE T ROWE ASSOCIATES INC /MD/ (491K shares), and NORGES BANK (481K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.